Loading...
•
Mar 28, 2020
Thermo Fisher Q1 2020 Earnings Report
Reported financial results for the first quarter ended March 28, 2020.
Key Takeaways
Thermo Fisher Scientific's first quarter revenue increased by 2% to $6.23 billion. GAAP diluted EPS decreased by 2% to $1.97, while adjusted EPS increased by 5% to $2.94.
First quarter revenue increased 2% to $6.23 billion.
First quarter GAAP diluted earnings per share (EPS) decreased 2% to $1.97.
First quarter adjusted EPS increased 5% to $2.94.
Announced agreement to acquire QIAGEN N.V. for $11.5 billion, expanding specialty diagnostics portfolio and enhancing life sciences offering.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
Thermo Fisher announced on April 6, 2020, that it withdrew its 2020 annual guidance due to the evolving COVID-19 pandemic and related customer impact.
Revenue & Expenses
Visualization of income flow from segment revenue to net income